Retrospective study of the immunogenicity and safety of the CoronaVac SARS-CoV-2 vaccine in people with underlying medical conditions

oleh: Chunmei Li, Hanfang Bi, Zhenwang Fu, Ao Li, Na Wan, Jun Hu, Fan Yang, Tai-Cheng Zhou, Yupeng Liang, Wei Su, Tianpei Shi, Mei Yang, Rong Wang, Wanting Qin, Xuanjing Yu, Hong-Yi Zheng, Zumi Zhou, Yong-Tang Zheng, Jia Wei, Gang Zeng, Zijie Zhang, the Precise-CoVaccine study group

Format: Article
Diterbitkan: Nature Portfolio 2022-11-01

Deskripsi

Li et al. evaluate the immunogenicity and safety of the CoronaVac inactivated COVID-19 vaccine in elderly patients with underlying medical conditions in China. Most patients show comparable neutralizing antibody and SARS-CoV-2-specific T cell responses to healthy controls, and no serious adverse effects are seen.